For nearly two years, a patent dispute quietly erased a health feature from millions of American wrists — a reminder that the tools we come to rely on exist within legal and commercial ecosystems as much as technological ones. Apple has now restored blood oxygen monitoring to its newest US Apple Watch models through a software update that shifts the computational work from watch to iPhone, satisfying import restrictions while returning a capability many users had come to depend on. The resolution, enabled by a fresh US Customs ruling, closes a chapter that began in 2023 when the International
Apple restores blood oxygen feature via iOS 18.6.1 workaround after patent dispute
Related Coverage
A woman was secretly filmed by someone wearing Meta's AI smart glasses in a viral prank video, raising concerns about we…
CBS News · Aug 21 Consumer groups urge FTC probe into AI firms' 'hoard-and-destroy' book practicesConsumer advocacy groups urge the FTC to investigate AI developers for allegedly buying, scanning, and destroying millio…
BBC News · Aug 21 Ofcom investigates Sky News over Farage family privacy claimsOfcom has launched an investigation into Sky News following harassment complaints by Reform UK leader Nigel Farage, who …
Pocket-lint · Aug 21 Amazon's Fire OS 16 Update Bypasses Fire Sticks EntirelyAmazon's new Fire OS 16 update will only launch on smart TVs, not Fire Sticks, as the company transitions all future sti…
Bias & Framing
Article presents Apple's workaround favorably with minimal critical analysis of patent dispute implications or Masimo's perspective.
Apple-centric narrative framing the workaround as a positive 'restoration' and 'latest development' without substantive examination of the underlying patent dispute merit or competitor impact.
Geopolitical Impact
Apple circumvents US patent ban on blood oxygen feature by processing data on iPhones instead of watches, restoring functionality through software workaround.
Demonstrates corporate adaptation to regulatory enforcement; highlights tension between innovation and intellectual property protection. Masimo's patent victory shows smaller health-tech firms can challenge tech giants, but Apple's workaround illustrates how large corporations can engineer solutions to maintain market presence despite legal restrictions.
Similar to pharmaceutical companies reformulating drugs to circumvent patent expirations or restrictions—legal workarounds that maintain competitive advantage while respecting regulatory boundaries.
Economic Lens
Apple circumvents patent dispute ban by processing blood oxygen data on iPhones instead of watches, restoring functionality to US Apple Watch models through software workaround.
US Apple Watch owners regain blood oxygen monitoring capability, though with reduced convenience (data viewed on iPhone Health app rather than watch display). Existing feature parity restored without hardware replacement, maintaining customer satisfaction and ecosystem lock-in.
Demonstrates regulatory workarounds in patent disputes; may prompt ITC to clarify enforcement mechanisms for software-based solutions. Could influence future patent litigation strategy in tech sector, particularly regarding data processing location requirements in import ban enforcement.